Business Description
Q-Line Biotech Ltd
ISIN : INE1G2W01011
Compare
Compare
Traded in other countries / regions
QLINE.India IPO Date
2026-05-29Description
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.88 | |||||
Debt-to-EBITDA | 2.57 | |||||
Interest Coverage | 5.25 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.85 | |||||
9-Day RSI | 57.59 | |||||
14-Day RSI | 59.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.48 | |||||
Quick Ratio | 0.97 | |||||
Days Inventory | 196.58 | |||||
Days Sales Outstanding | 63.42 | |||||
Days Payable | 115.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.17 | |||||
Operating Margin % | 22.2 | |||||
Net Margin % | 8.97 | |||||
EBITDA Margin % | 20.65 | |||||
FCF Margin % | -18.35 | |||||
OCF Margin % | -0.42 | |||||
ROE % | 15.99 | |||||
ROA % | 7.08 | |||||
ROIC % | 11.77 | |||||
ROC (Joel Greenblatt) % | 24.4 | |||||
ROCE % | 24.18 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 45.32 | |||||
PE Ratio without NRI | 19.09 | |||||
PS Ratio | 4.06 | |||||
PB Ratio | 6.71 | |||||
Price-to-Tangible-Book | 7.67 | |||||
EV-to-EBIT | 26.41 | |||||
EV-to-EBITDA | 23.42 | |||||
EV-to-Revenue | 4.84 | |||||
EV-to-FCF | -26.35 | |||||
Price-to-Graham-Number | 2.55 | |||||
Earnings Yield (Greenblatt) % | 3.79 | |||||
FCF Yield % | -4.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Q-Line Biotech Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,137.804 | ||
| EPS (TTM) (₹) | 12.059 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 59.96 | ||
| 14-Day ATR (₹) | 30.466654 | ||
| 20-Day SMA (₹) | 512.1675 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 431 - 600 | ||
| Shares Outstanding (Mil) | 23.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Q-Line Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Q-Line Biotech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Q-Line Biotech Ltd Frequently Asked Questions
What is Q-Line Biotech Ltd(NSE:QLINE)'s stock price today?
The current price of NSE:QLINE is ₹546.50. The 52 week high of NSE:QLINE is ₹600.00 and 52 week low is ₹431.00.
When is next earnings date of Q-Line Biotech Ltd(NSE:QLINE)?
The next earnings date of Q-Line Biotech Ltd(NSE:QLINE) is .
Does Q-Line Biotech Ltd(NSE:QLINE) pay dividends? If so, how much?
Q-Line Biotech Ltd(NSE:QLINE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Q-Line Biotech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers